Best Somatostatin Analog for pancreatic neoplasms
The 2 Somatostatin Analog options we list for pancreatic neoplasms are all Octreotide Acetate— the same active ingredient in different brands or formulations, so they aren’t ranked against each other on effectiveness. Our score reflects each product’s FDA recall-safety record; the practical choice is brand vs generic, dose, and cost. Compare them with all treatments for pancreatic neoplasms or the full Somatostatin Analog class. Not medical advice — always consult a professional.
Quick answer: Of the 2 somatostatin analog drugs we rate for pancreatic neoplasms, all are available as lower-cost generics, and most are injectable. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for pancreatic neoplasms; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for pancreatic neoplasms
These are all Octreotide Acetatein different brands or formulations, so we don’t rank them against each other — the list below is for comparing brand vs generic, dose, and typical cost, not for picking a “best” one on effectiveness.
All 2 somatostatin analog products
sandostatin
PrescriptionFDA-sourced
Sandostatin (Octreotide Acetate) is a somatostatin analog used to treat Acromegaly, Adenoma, Diarrhea, Pancreatic Neoplasms.
Pharmacy pays
$5.34 /mL
bynfezia pen
PrescriptionFDA-sourced
Bynfezia Pen (Octreotide Acetate) is a somatostatin analog used to treat Acromegaly, Adenoma, Diarrhea, Pancreatic Neoplasms.
Pharmacy pays
$5.34 /mL
Frequently asked
- What is the best somatostatin analog for pancreatic neoplasms?
- The Somatostatin Analog options we list for pancreatic neoplasms are all Octreotide Acetate — the same active ingredient in different brands or formulations — so there's no single "best" one on effectiveness; the practical choice is brand vs generic, dose, and cost. Always consult a professional.
- Which somatostatin analog drugs treat pancreatic neoplasms?
- pharmaranks lists 2 Somatostatin Analog products used for pancreatic neoplasms, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.